# Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products--Chemistry, Manufacturing, and Controls Documentation:  Guidance for Industry – FDA Guidance

Source: https://www.keypedia.com/guidances/guidance-document/nasal-spray-and-inhalation-solution-suspension-and-spray-drug-products-chemistry-manufacturing-and-controls-documentation-guidance-for-industry/39c6d463-15aa-443b-847e-8eb8baa08474

> FDA guidance document: Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products--Chemistry, Manufacturing, and Controls Documentation:  Guidance for Industry. Issue date: July 05, 2002. Get complete insights and analysis.

---

## Details

- Title: Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products--Chemistry, Manufacturing, and Controls Documentation:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2002-07-05
- Last Changed: 2020-05-14
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-1999-D-0060">FDA-1999-D-0060</a>

## Related Documents

- [Adverse Reactions Section of Labeling for Human Prescription Drug and Biological Products — Content and Format](https://www.keypedia.com/guidances/guidance-document/adverse-reactions-section-of-labeling-for-human-prescription-drug-and-biological-products-content-and-format/b6150333-b5b8-4dc4-96ca-a0540463e9a1)
- [M4S: The CTD -- Safety](https://www.keypedia.com/guidances/guidance-document/m4s-the-ctd-safety/3d4fa9c6-5f48-4dc5-b89c-00dd678bc870)
- [Nonclinical Safety Evaluation of Pediatric Drug Products](https://www.keypedia.com/guidances/guidance-document/nonclinical-safety-evaluation-of-pediatric-drug-products/a5729b5c-7a6e-40c1-861d-e8acf3cd178a)